Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 14, 2016; 22(26): 6065-6075
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6065
Published online Jul 14, 2016. doi: 10.3748/wjg.v22.i26.6065
Overall survival | Univariate analysis (Cox regression) | Multivariable analysis (Cox regression) | |||
HR (95%CI) | P-value | HR (95%CI) | P-value | ||
Primary site | BTC | Ref | Ref | ||
Pancreas | 1.6 (0.8-2.9) | 0.153 | 1.5 (0.8-2.8) | 0.205 | |
Stage | Locally advanced | Ref | Ref | ||
Metastatic | 1.6 (0.99-2.9) | 0.067 | 1.8 (1.06-2.9) | 0.029 | |
ECOG-PS | 0/1 | Ref | Ref | ||
≥ 2 | 0.9 (0.5-1.6) | 0.748 | 0.9 (0.5-1.6) | 0.716 | |
Stent-related event | No-SRE group | Ref | Ref | ||
SRE group | 0.7 (0.4-1.1) | 0.098 | 0.6 (0.4-1.01) | 0.205 |
- Citation: Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy. World J Gastroenterol 2016; 22(26): 6065-6075
- URL: https://www.wjgnet.com/1007-9327/full/v22/i26/6065.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i26.6065